Evaluation of Atorvastatin Treatment on Carotid Plaque.
Status:
Terminated
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the effect of 18 months treatment with atorvastatin
80mg or atorvastatin 10mg on the carotid vessel plaque morphology, in particular, the effect
on evident necrotic lipid rich core of the plaque in patients.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.